<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="343134">
  <stage>Registered</stage>
  <submitdate>29/06/2011</submitdate>
  <approvaldate>18/07/2011</approvaldate>
  <actrnumber>ACTRN12611000753954</actrnumber>
  <trial_identification>
    <studytitle>Repairing a deep donor site using a new, dissolvable, plastic scaffold.</studytitle>
    <scientifictitle>An evaluation of function and appearance following reconstruction of a free-flap donor site after biodegradable polymer implant incorporation and secondary split skin grafting.</scientifictitle>
    <utrn>Nil</utrn>
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Post harvest Free flap donor site appearance and function</healthcondition>
    <conditioncode>
      <conditioncode1>Skin</conditioncode1>
      <conditioncode2>Other skin conditions</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Following free-flap harvest (either anterolateral thigh flap or radial forearm flap), a biodegradable polyurethane dermal matrix sealed with a non-biodegradable polyurethane film will be implanted into the donor site. When integrated, the film is removed and a thin split skin graft applied to the integrated neo-dermis.</interventions>
    <comparator>Comparison will be made against data collected in 2010 and 2011 in porcine wounds of similar depth where a variety of treatments were employed. These included healing by secondary intention, implantation of unsealed polymer matrices, implantation of sealed polymer matrices, matrices with immediate split skin graft application, matrices with delayed split-skin graft application, matrices with sealing membranes of different thicknesses.</comparator>
    <control>Historical</control>
    <interventioncode>Treatment: Devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Appearance of the donor site compared to historical data. Assessment will be by clinical appearance (incorporation of the foam is visible and progressive to day 7 then consolidates), ease of delamination of the sealing membrane in historical comparison to Integra dermal regeneration template, Visitrak wound measurement to assess degree of contraction.</outcome>
      <timepoint>Weekly to 6 weeks, then monthly to 12 months</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Function of the donor site compared to historical data. This will be assessed by clinical means (pinching, shearing mobility, visibilty or otherwise of deeper structures (eg tendons in free radial forearm flap donor sites).</outcome>
      <timepoint>Weekly to 6 weeks, then monthly to 12 months</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Ability to provide informed consent; requirement for free-flap surgery involving either anterolateral thigh flap or radial forearm flapfree</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>70</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Pregnancy, severe debility precluding second anaesthetic; inability to provide informed consent</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment>Full discussion with patient deemed to need one of the two free flaps mentioned previously; acquisition of informed consent if willing.</concealment>
    <sequence>Nil</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/10/2011</anticipatedstartdate>
    <actualstartdate>29/08/2012</actualstartdate>
    <anticipatedenddate />
    <actualenddate>28/07/2013</actualenddate>
    <samplesize>10</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up continuing</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>NovoSkin Pty Ltd</primarysponsorname>
    <primarysponsoraddress>38 Tom Packer Drive, Athelstone 5076, South Australia</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>NovoSkin Pty Ltd</fundingname>
      <fundingaddress>38, Tom Packer Drive, Athelstone 5076, South Australia</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Hospital</sponsortype>
      <sponsorname>Royal Adelaide Hospital</sponsorname>
      <sponsoraddress>Department of Plastic and Reconstructive Surgery, Royal Adelaide Hospital, North Terrace, Adelaide 5000, South Australia</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Single group study of efficacy in improving free flap donor sites by first integrating a biodegradable polyurethane dermal matrix before skin grafting.</summary>
    <trialwebsite />
    <publication>- Li A, Dearman BL, Crompton KE, Moore TG, Greenwood JE. Evaluation of a novel biodegradable polymer for the generation of a dermal matrix. Journal of Burn Care and Research 2009;30(4):717-728.
- Greenwood JE, Li A, Dearman BL, Moore TG. Evaluation of NovoSorb novel biodegradable polymer for the generation of a dermal matrix. Part 1: In-vitro studies. Wound Practice and Research 2010;18(1):14-22.
- Greenwood JE, Li A, Dearman BL, Moore TG. Evaluation of NovoSorb novel biodegradable polymer for the generation of a dermal matrix. Part 2: In-vivo studies. Wound Practice and Research 2010;18(1):24-34.
- Greenwood JE. Biodegradable polyurethane as a dermal matrix. Journal of Burn Care and Research 2011; 32(2) (supplement):S58.
- Greenwood JE, Dearman BL. Split-skin graft application over an integrating, biodegradable temporising polymer matrix: Immediate and delayed. Journal of Burn Care and Research (accepted).
- Greenwood JE, Dearman BL. Comparison of a sealed, NovoSorb biodegradable temporising matrix (BTM) against Integra: a prospective, porcine study. Journal of Burn Care and Research (accepted).</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Royal Adelaide Hospital Human Research Ethics Committee</ethicname>
      <ethicaddress>Level 3, Hanson Institute (IMVS Building)
Royal Adelaide Hospital, North Terrace, Adelade 5000, South Australia</ethicaddress>
      <ethicapprovaldate>23/06/2011</ethicapprovaldate>
      <hrec>110613</hrec>
      <ethicsubmitdate>16/06/2011</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>A/Prof</title>
      <name>John E Greenwood</name>
      <address>Adult Burn Centre, Royal Adelaide Hospital, North Terrace, Adelaide 5000, South Australia</address>
      <phone>+61 8 8222 2233</phone>
      <fax>+61 8 8222 5676</fax>
      <email>john.greenwood@health.sa.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>John E Greenwood</name>
      <address>Adult Burn Centre, Royal Adelaide Hospital, North Terrace, Adelaide 5000, South Australia</address>
      <phone>+61 8 8222 2233</phone>
      <fax>+61 8 8222 5676</fax>
      <email>john.greenwood@health.sa.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>John E Greenwood</name>
      <address>Adult Burn Centre, Royal Adelaide Hospital, North Terrace, Adelaide 5000, South Australia</address>
      <phone>+61 8 8222 2233</phone>
      <fax>+61 8 8222 5676</fax>
      <email>john.greenwood@health.sa.gov.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>John E Greenwood</name>
      <address>Adult Burn Centre, Royal Adelaide Hospital, North Terrace, Adelaide 5000, South Australia</address>
      <phone>+61 8 8222 2233</phone>
      <fax>+61 8 8222 5676</fax>
      <email>john.greenwood@health.sa.gov.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>